David A. Spellman, SVP, CFO and Treasurer at Akebia Therapeutics, Inc. (AKBA), sold 790 shares at $3.40 ($3K) on 2021-04-01, disclosed to the SEC on 2021-04-01.
Open-market sale of $3k AKBA by SVP, CFO and Treasurer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| AKBA | SELL | 2023-03-01 | $6K | — | Filing → |
| AKBA | SELL | 2022-03-02 | $18K | — | Filing → |